Copper in Alzheimer's disease: Implications in amyloid aggregation and neurotoxicity

被引:32
|
作者
Gamez, Patrick [1 ,2 ]
Caballero, Ana B. [1 ]
机构
[1] Univ Barcelona, Dept Quim Inorgan, QBI, Barcelona 08028, Spain
[2] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain
来源
AIP ADVANCES | 2015年 / 5卷 / 09期
关键词
MILD COGNITIVE IMPAIRMENT; A-BETA PEPTIDES; METAL-IONS; SENILE PLAQUES; BINDING-SITE; IN-VITRO; NEURODEGENERATIVE DISEASES; COORDINATION GEOMETRY; OXIDATION CHEMISTRY; CEREBROSPINAL-FLUID;
D O I
10.1063/1.4921314
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The relationship of copper dyshomeostasis with neurodegenerative diseases has become evident in the last years. Because of the major role that this metal ion plays in biological processes, most of which being located in the brain, it is not surprising that changes in its distribution are closely related with the advent of neurodegenerative disorders such as Alzheimer's disease (AD). An increasing number of works have dealt with this subject in the last years, and opened an intense debate in some points while raising new questions that still remain unanswered. This revision work puts together and discusses the latest findings and insights on how copper ions are involved in AD progression, including its interaction with A beta and its consequently induced aggregation. (C) 2015 Author(s).
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Copper binding to the Alzheimer's disease amyloid precursor protein
    Kong, Geoffrey K. -W.
    Miles, Luke A.
    Crespi, Gabriela A. N.
    Morton, Craig J.
    Ng, Hooi Ling
    Barnham, Kevin J.
    McKinstry, William J.
    Cappai, Roberto
    Parker, Michael W.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2008, 37 (03): : 269 - 279
  • [32] Synaptic Copper, Amyloid-β, and Neurotransmitters in Alzheimer's Disease
    Nam, Eunju
    Nam, Geewoo
    Lim, Mi Hee
    BIOCHEMISTRY, 2020, 59 (01) : 15 - 17
  • [33] Copper binding to the Alzheimer’s disease amyloid precursor protein
    Geoffrey K.-W. Kong
    Luke A. Miles
    Gabriela A. N. Crespi
    Craig J. Morton
    Hooi Ling Ng
    Kevin J. Barnham
    William J. McKinstry
    Roberto Cappai
    Michael W. Parker
    European Biophysics Journal, 2008, 37 : 269 - 279
  • [34] Embelin Mitigates Amyloid-β-Induced Neurotoxicity and Cognitive Impairment in Rats: Potential Therapeutic Implications for Alzheimer's Disease
    Arora, Rimpi
    Deshmukh, Rahul
    MOLECULAR NEUROBIOLOGY, 2025, 62 (02) : 1577 - 1590
  • [35] Catecholamine compounds as inhibitors of amyloid β-42 aggregation in Alzheimer's disease
    Johnson, Caitlin
    Gravelle, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [36] In vitro study of the mechanism of intraneuronal β-amyloid aggregation in Alzheimer's disease
    Alsunusi, Shahad
    Kumosani, Taha A.
    Glabe, Charles G.
    Huwait, Etimad A.
    Moselhy, Said S.
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 128 (03) : 732 - 739
  • [37] Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease
    Kumar, N. Satheesh
    Nisha, N.
    CHINESE JOURNAL OF NATURAL MEDICINES, 2014, 12 (11) : 801 - 818
  • [38] Aggregation Mechanisms and Molecular Structures of Amyloid-β in Alzheimer's Disease
    Niu, Zheng
    Gui, Xinrui
    Feng, Shuang
    Reif, Bernd
    CHEMISTRY-A EUROPEAN JOURNAL, 2024, 30 (48)
  • [39] Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease
    N.Satheesh Kumar
    N.Nisha
    Chinese Journal of Natural Medicines, 2014, 12 (11) : 801 - 818
  • [40] Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease
    Tian, Yanli
    Zhang, Xueli
    Li, Yuyan
    Shoup, Timothy M.
    Teng, Xin
    Elmaleh, David R.
    Moore, Anna
    Ran, Chongzhao
    CHEMICAL COMMUNICATIONS, 2014, 50 (99) : 15792 - 15795